Conmed CNMD
NYSE CNMD
$51.07 -0.31 (-0.60%)
At close: Aug 21, 2026 · 4:00 PM EDT

Conmed (CNMD) Asset Writedowns and Impairment (2021)

Conmed's (CNMD) quarterly Asset Writedowns and Impairment came in at $899000.0 in Q3 2021.

Conmed (CNMD) Asset Writedowns and Impairment (2021) Analysis & Trends

Conmed (CNMD) has 1 years of Asset Writedowns and Impairment data on file, last reported at $899000.0 in Q3 2021.

  • Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $899000.0 in Q3 2021, while the trailing twelve-month figure through Dec 2022 was $899000.0 (changed N/A YoY) and the FY2025 annual result came in at $363000.0, changed N/A from the prior year.
  • Asset Writedowns and Impairment steadied at $899000.0 in Q3 2021.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $899000.0 in Q3 2021 to a low of $899000.0 in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Conmed 1.54 Bn 1.50 Bn 197.46 Mn

Historic Data

Download Data
DateValue
Sep 30, 2021 899,000.00
Sep 30, 2021 899,000.00